Publication | Closed Access

Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway

Oncogenic AgentNovel Tacrine PlatinumTelomerase ActivityMolecular BiologyAnti-cancer AgentTumor SuppressorMedicineCell BiologyTumor MicroenvironmentCancer Research